RNA: the balance sheet

MyFinsight

For the year ending 2025-12-31, RNA has $1,958,050K in assets. $269,450K in debts. $382,517K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	382,517
Marketable securities	1,314,352
Prepaid and other current assets	101,598
Total current assets	1,798,467
Property and equipment, net	23,333
Restricted cash	2,797
Right-of-use assets	51,278
Other assets	82,175
Total assets	1,958,050

Accrued manufacturing and technical development	12,403
Accrued expenses and other liabilities	157,466
Lease liabilities, current portion	3,938
Deferred revenue, current portion	21,639
Total current liabilities	195,446
Lease liabilities, net of current portion	45,313
Deferred revenue, net of current portion	28,691
Total liabilities	269,450
Common stock, 0.0001 par value authorized shares 400,000 issued and outstanding shares 151,205 and 119,893 at december31, 2025 and 2024, respectively	15
Additional paid-in capital	3,263,720
Accumulated other comprehensive income	2,562
Accumulated deficit	-1,577,697
Total stockholders equity	1,688,600
Total liabilities and stockholders equity	1,958,050

Unit: Thousand (K) dollars (except for numbers of shares and EPS).